Atomi Financial Group Inc. Grows Position in UnitedHealth Group Incorporated (NYSE:UNH)

Atomi Financial Group Inc. grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.3% during the fourth quarter, HoldingsChannel.com reports. The fund owned 7,247 shares of the healthcare conglomerate’s stock after buying an additional 432 shares during the quarter. Atomi Financial Group Inc.’s holdings in UnitedHealth Group were worth $3,666,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in UNH. Kathleen S. Wright Associates Inc. bought a new position in shares of UnitedHealth Group during the 3rd quarter valued at $27,000. Global Wealth Strategies & Associates lifted its holdings in UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after acquiring an additional 32 shares during the period. West Financial Advisors LLC bought a new stake in shares of UnitedHealth Group during the 3rd quarter valued at about $32,000. Quarry LP lifted its stake in shares of UnitedHealth Group by 132.1% in the 2nd quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock worth $33,000 after purchasing an additional 37 shares during the period. Finally, RPg Family Wealth Advisory LLC bought a new stake in UnitedHealth Group during the third quarter valued at approximately $37,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $524.78 on Wednesday. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a market cap of $482.95 billion, a price-to-earnings ratio of 33.86, a PEG ratio of 1.38 and a beta of 0.62. The firm’s fifty day moving average is $547.07 and its 200 day moving average is $563.84. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm’s revenue was up 6.8% on a year-over-year basis. During the same quarter last year, the business posted $5.83 earnings per share. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.77 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were issued a $2.10 dividend. The ex-dividend date was Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.60%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the stock. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Stephens upped their price target on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Barclays cut their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research note on Friday, January 17th. UBS Group lowered their price target on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Finally, Bank of America decreased their price objective on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Two equities research analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of $627.74.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.